List of Tables

Table 1. Bispecific Antibodies Drug Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Bispecific Antibodies Drug Market Restraints

Table 3. Bispecific Antibodies Drug Market Trends

Table 4. Bispecific Antibodies Drug Industry Policy

Table 5. Global Bispecific Antibodies Drug Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Bispecific Antibodies Drug Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Bispecific Antibodies Drug Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 8. Global Bispecific Antibodies Drug Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Bispecific Antibodies Drug Average Selling Price (ASP) by Company, (2020-2025) & (US$/Unit)

Table 10. Global Bispecific Antibodies Drug Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Bispecific Antibodies Drug Mergers & Acquisitions, Expansion Plans

Table 12. Global Bispecific Antibodies Drug Manufacturers Product Type

Table 13. Head Office and Bispecific Antibodies Drug Production Site of Key Manufacturer

Table 14. Bispecific Antibodies Drug Capacity of Major Manufacturers and Future Plan

Table 15. China Bispecific Antibodies Drug Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Bispecific Antibodies Drug Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Bispecific Antibodies Drug Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 18. China Bispecific Antibodies Drug Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Bispecific Antibodies Drug Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Units)

Table 20. Global Bispecific Antibodies Drug Production by Region, 2020-2025, (K Units)

Table 21. Global Bispecific Antibodies Drug Production Forecast by Region, 2026-2031, (K Units)

Table 22. Global Key Players of Bispecific Antibodies Drug Upstream (Raw Materials)

Table 23. Global Bispecific Antibodies Drug Typical Customers

Table 24. Bispecific Antibodies Drug Typical Distributors

Table 25. by Type, Global Bispecific Antibodies Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Bispecific Antibodies Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Bispecific Antibodies Drug Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Bispecific Antibodies Drug Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Bispecific Antibodies Drug Sales Quantity, 2020-2031, (K Units)

Table 30. By Country, Global Bispecific Antibodies Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Bispecific Antibodies Drug Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Bispecific Antibodies Drug Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Bispecific Antibodies Drug Sales Quantity, 2020-2031, (K Units)

Table 34. By Country, Global Bispecific Antibodies Drug Sales Quantity Market Share, 2020-2031

Table 35. Amgen Company Information, Head Office, Market Area, and Industry Position

Table 36. Amgen Bispecific Antibodies Drug Models, Specifications, and Application

Table 37. Amgen Bispecific Antibodies Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 38. Amgen Company Profile and Main Business

Table 39. Amgen Recent Developments

Table 40. Immunocore Company Information, Head Office, Market Area, and Industry Position

Table 41. Immunocore Bispecific Antibodies Drug Models, Specifications, and Application

Table 42. Immunocore Bispecific Antibodies Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 43. Immunocore Company Profile and Main Business

Table 44. Immunocore Recent Developments

Table 45. Roche Company Information, Head Office, Market Area, and Industry Position

Table 46. Roche Bispecific Antibodies Drug Models, Specifications, and Application

Table 47. Roche Bispecific Antibodies Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 48. Roche Company Profile and Main Business

Table 49. Roche Recent Developments

List of Figures

Figure 1. Bispecific Antibodies Drug Picture

Figure 2. Global Bispecific Antibodies Drug Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Bispecific Antibodies Drug Sales Quantity, (K Units) & (2020-2031)

Figure 4. Global Bispecific Antibodies Drug Average Selling Price (ASP), (2020-2031) & (US$/Unit)

Figure 5. China Bispecific Antibodies Drug Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Bispecific Antibodies Drug Sales Quantity (K Units) & (2020-2031)

Figure 7. China Bispecific Antibodies Drug Average Selling Price (ASP), (US$/Unit) & (2020-2031)

Figure 8. By Consumption Value, China Bispecific Antibodies Drug Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Bispecific Antibodies Drug Market Share of Global, 2020-2031

Figure 10. Global Bispecific Antibodies Drug Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Bispecific Antibodies Drug Key Participants, Market Share, 2024

Figure 12. Global Bispecific Antibodies Drug Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Bispecific Antibodies Drug Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Bispecific Antibodies Drug Production Market Share & Forecast by Region, 2020-2031

Figure 15. Bispecific Antibodies Drug Industry Chain

Figure 16. Bispecific Antibodies Drug Procurement Model

Figure 17. Bispecific Antibodies Drug Sales Model

Figure 18. Bispecific Antibodies Drug Sales Channels, Direct Sales, and Distribution

Figure 19. Blincyto

Figure 20. Kimmtrak

Figure 21. Hemlibra

Figure 22. by Type, Global Bispecific Antibodies Drug Consumption Value, 2020-2031, US$ Million

Figure 23. by Type, Global Bispecific Antibodies Drug Consumption Value Market Share, 2020-2031

Figure 24. by Type, Global Bispecific Antibodies Drug Sales Quantity, 2020-2031, (K Units)

Figure 25. by Type, Global Bispecific Antibodies Drug Sales Quantity Market Share, 2020-2031

Figure 26. by Type, Global Bispecific Antibodies Drug Average Selling Price (ASP), 2020-2031, (US$/Unit)

Figure 27. Hematological Cancers

Figure 28. Solid Tumors

Figure 29. by Application, Global Bispecific Antibodies Drug Consumption Value, 2020-2031, US$ Million

Figure 30. by Application, Global Bispecific Antibodies Drug Revenue Market Share, 2020-2031

Figure 31. by Application, Global Bispecific Antibodies Drug Sales Quantity, 2020-2031, (K Units)

Figure 32. by Application, Global Bispecific Antibodies Drug Sales Quantity Market Share, 2020-2031

Figure 33. by Application, Global Bispecific Antibodies Drug Price, 2020-2031, (US$/Unit)

Figure 34. By Region, Global Bispecific Antibodies Drug Consumption Value Market Share, 2020-2031

Figure 35. By Region, Global Bispecific Antibodies Drug Sales Quantity Market Share, 2020-2031

Figure 36. North America Bispecific Antibodies Drug Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 37. By Country, North America Bispecific Antibodies Drug Consumption Value Market Share, 2024

Figure 38. Europe Bispecific Antibodies Drug Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 39. By Country, Europe Bispecific Antibodies Drug Consumption Value Market Share, 2024

Figure 40. Asia Pacific Bispecific Antibodies Drug Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 41. By Country/Region, Asia Pacific Bispecific Antibodies Drug Consumption Value Market Share, 2024

Figure 42. South America Bispecific Antibodies Drug Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 43. By Country, South America Bispecific Antibodies Drug Consumption Value Market Share, 2024

Figure 44. Middle East & Africa Bispecific Antibodies Drug Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 45. United States Bispecific Antibodies Drug Sales Quantity, 2020-2031, (K Units)

Figure 46. by Type, United States Bispecific Antibodies Drug Sales Quantity Market Share, 2024 VS 2031

Figure 47. by Application, United States Bispecific Antibodies Drug Sales Quantity Market Share, 2024 VS 2031

Figure 48. Europe Bispecific Antibodies Drug Sales Quantity, 2020-2031, (K Units)

Figure 49. by Type, Europe Bispecific Antibodies Drug Sales Quantity Market Share, 2024 VS 2031

Figure 50. by Application, Europe Bispecific Antibodies Drug Sales Quantity Market Share, 2024 VS 2031

Figure 51. China Bispecific Antibodies Drug Sales Quantity, 2020-2031, (K Units)

Figure 52. by Type, China Bispecific Antibodies Drug Sales Quantity Market Share, 2024 VS 2031

Figure 53. by Application, China Bispecific Antibodies Drug Sales Quantity Market Share, 2024 VS 2031

Figure 54. Japan Bispecific Antibodies Drug Sales Quantity, 2020-2031, (K Units)

Figure 55. by Type, Japan Bispecific Antibodies Drug Sales Quantity Market Share, 2024 VS 2031

Figure 56. by Application, Japan Bispecific Antibodies Drug Sales Quantity Market Share, 2024 VS 2031

Figure 57. South Korea Bispecific Antibodies Drug Sales Quantity, 2020-2031, (K Units)

Figure 58. by Type, South Korea Bispecific Antibodies Drug Sales Quantity Market Share, 2024 VS 2031

Figure 59. by Application, South Korea Bispecific Antibodies Drug Sales Quantity Market Share, 2024 VS 2031

Figure 60. Southeast Asia Bispecific Antibodies Drug Sales Quantity, 2020-2031, (K Units)

Figure 61. by Type, Southeast Asia Bispecific Antibodies Drug Sales Quantity Market Share, 2024 VS 2031

Figure 62. by Application, Southeast Asia Bispecific Antibodies Drug Sales Quantity Market Share, 2024 VS 2031

Figure 63. India Bispecific Antibodies Drug Sales Quantity, 2020-2031, (K Units)

Figure 64. by Type, India Bispecific Antibodies Drug Sales Quantity Market Share, 2024 VS 2031

Figure 65. by Application, India Bispecific Antibodies Drug Sales Quantity Market Share, 2024 VS 2031

Figure 66. Middle East & Africa Bispecific Antibodies Drug Sales Quantity, 2020-2031, (K Units)

Figure 67. by Type, Middle East & Africa Bispecific Antibodies Drug Sales Quantity Market Share, 2024 VS 2031

Figure 68. by Application, Middle East & Africa Bispecific Antibodies Drug Sales Quantity Market Share, 2024 VS 2031

Figure 69. Research Methodology

Figure 70. Breakdown of Primary Interviews

Figure 71. Bottom-up Approaches

Figure 72. Top-down Approaches